KNOWBASE
KB-041Under Trial

The Sterling Biotech Bank Fraud

A pharma group borrowed ₹8,100 crore, then its promoters fled to Nigeria on Albanian passports and incorporated over 100 shell entities worldwide to move the money — becoming, by the ED's own account, formally declared fugitives.

Banking & FinancePublished 7 September 2026Updated 7 September 2026
₹8,100 cr
bank fraud alleged; with interest, the ED put the figure above ₹16,000 cr
Share on XShare on WhatsApp
01

The Promise

Loans extended to Sterling Biotech and related Sandesara Group companies will be used for their disclosed pharmaceutical business purpose and repaid according to sanctioned terms.

Sterling Biotech Ltd., under promoters Nitin and Chetan Sandesara, Gujarat-based pharmaceutical company; borrower from a bank consortium · 1 January 2010

The Sandesara brothers and associates allegedly laundered loan proceeds through more than 100 entities incorporated across the US, UAE, UK, British Virgin Islands, Mauritius, Barbados, and Nigeria.

02

The Standard

Loan funds used for their disclosed pharmaceutical-business purpose, with no layered international laundering of proceeds.

Standard bank lending covenants and India's Prevention of Money Laundering Act.

In force from 1 January 2010

03

The Reality

The Sandesara brothers left India for Nigeria in 2017 using Albanian passports, evading arrest as the fraud was uncovered. A Delhi court declared Nitin Sandesara, Chetan Sandesara, Chetan's wife Dipti, and their brother-in-law Hiteshkumar Patel fugitive economic offenders. Interpol notices were issued, and Nitin Sandesara was briefly detained in Dubai in 2018 but has not been extradited to India.

As of 1 January 2019

04

The Gap

05

Timeline

  1. Status
    Sandesara brothers flee to Nigeria

    The promoters leave India using Albanian passports as the fraud investigation intensifies.

  2. Status
    Nitin Sandesara briefly detained in Dubai

    He is held temporarily but not extradited to India.

  3. Status
    Declared fugitive economic offenders

    A Delhi court declares four individuals connected to the case fugitives under the Fugitive Economic Offenders Act.

06

Legal Status

The principal accused remain fugitives abroad and have not faced trial in India. No conviction has been recorded.

Nitin Sandesara
Promoter, Sterling Biotech / Sandesara Group

Fled India, 2017; declared a fugitive economic offender, 2019; briefly detained in Dubai, 2018, but not extradited. No Indian trial verdict.

Chetan Sandesara
Promoter, Sterling Biotech / Sandesara Group

Fled India alongside his brother; declared a fugitive economic offender, 2019. No Indian trial verdict.

07

Verdict

Under TrialMedium confidence

Preliminary verdict, pending fuller research: the scale of the alleged fraud and the promoters' fugitive status are well documented and formally adjudicated under the Fugitive Economic Offenders Act. What remains unresolved, years later, is any actual trial or conviction, since the principal accused have avoided Indian jurisdiction entirely.

The fugitive-economic-offender declarations are a matter of court record. Confidence is not higher because no criminal trial has tested the underlying fraud allegations, and this investigation has not confirmed the current status of extradition efforts.

08

What remains incomplete

  • This is a stub entry. The current status of India's extradition efforts, including any 2025–2026 developments, has not been researched.
  • No confirmed asset-recovery figure was found in the sources reviewed.
  • The role of Ahmed Patel, who was separately questioned by the ED in a related matter per contemporaneous reporting, has not been clarified in this entry.
09

Sources

Independent source1 January 2024
Sterling Biotech loan fraud
Wikipedia, citing contemporaneous reporting
View source
Independent source1 January 2019
Sterling Biotech fraud case: Sandesara brothers declared fugitive economic offenders by Delhi court
Scroll.in
View source